Zealand Pharma Loses Fifth of Value After Trial Dropouts
Danish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
Not all investors can use a backdoor Roth. This intro clarifies eligibility and the basic implementation steps.
27,524 articlesDanish biotech Zealand Pharma saw its stock slide after disclosing a 20% dropout rate in its weight-loss drug trial d...
A cybersecurity ETF surged roughly 40% in the last month, signaling a shift in investor sentiment toward AI-enabled d...
Kalshi launches LINKPERP, a CFTC-regulated Chainlink perpetual contract, coinciding with LINK ETF assets surpassing $...
May CPI data show inflation just roared back above 4% driven by energy costs, while some grocery prices ease. Investo...
Nightrush.com announces a major editorial and platform revamp to match AI-driven personalization in iGaming, with a f...
XRP is testing a pivotal support area after a steep two-week selloff. The bounce remains fragile, keeping downside ri...
LBank will stage a VIP Matchday around the Argentina vs Austria World Cup 2026 clash at AT&T Stadium in Dallas, spotl...
SpaceX's potential IPO is being framed by analysts as a possible catalyst for renewed public-market activity after ye...
Crypto funds see bitcoin potentially near a bottom as inflows return and risk appetite rekindles, signaling a potenti...
Builders entered the mid-year period wary, as tepid spring selling collided with strong headwinds for loans and mortg...
In a live Fox Business showdown, Peter Schiff and Anthony Pompliano spar over Bitcoin's future. Schiff questions intr...
A pair of 84-foot-tall towers moving through Los Angeles approvals could redefine housing reform in the city. The Riv...